Drug Free Valuation
| DSOL Stock | USD 0 0.00 0.00% |
Drug Free seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Drug Free Solution from reviewing the firm fundamentals such as EBITDA of (862.83 K), price to earning of (1.56) X, and Current Valuation of 496.08 K as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Drug Free's price fluctuation is very steady at this time. Calculation of the real value of Drug Free Solution is based on 3 months time horizon. Increasing Drug Free's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Drug pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Drug Free Solution. Since Drug Free is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Drug Pink Sheet. However, Drug Free's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0011 | Real 9.24E-4 | Hype 0.0011 | Naive 0.0011 |
The intrinsic value of Drug Free's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Drug Free's stock price.
Estimating the potential upside or downside of Drug Free Solution helps investors to forecast how Drug pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Drug Free more accurately as focusing exclusively on Drug Free's fundamentals will not take into account other important factors: Drug Free Total Value Analysis
Drug Free Solution is currently estimated to have valuation of 496.08 K with market capitalization of 503.2 K, debt of 0, and cash on hands of 7.12 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Drug Free fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
496.08 K | 503.2 K | 0 | 7.12 K |
Drug Free Asset Utilization
One of the ways to look at asset utilization of Drug is to check how much profit was generated for every dollar of assets it reports. Drug Free Solution shows a negative utilization of assets of -12.7 percent, losing $0.13 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Drug Free Solution shows how discouraging it operates for each dollar spent on its assets.Drug Free Profitability Analysis
Net Loss for the year was (755.87 K) with loss before overhead, payroll, taxes, and interest of (171.22 K).About Drug Free Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Drug Free Solution. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Drug Free Solution based exclusively on its fundamental and basic technical indicators. By analyzing Drug Free's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Drug Free's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Drug Free. We calculate exposure to Drug Free's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Drug Free's related companies.Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. The company was formerly known as Living Breath Project, Inc. and changed its name to Drug Free Solution, Inc. in January 2014. DRUG FREE is traded on PNK Exchange in the United States.
8 Steps to conduct Drug Free's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Drug Free's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Drug Free's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Drug Free's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Drug Free's revenue streams: Identify Drug Free's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Drug Free's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Drug Free's growth potential: Evaluate Drug Free's management, business model, and growth potential.
- Determine Drug Free's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Drug Free's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Drug Pink Sheet
Drug Free financial ratios help investors to determine whether Drug Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Drug with respect to the benefits of owning Drug Free security.